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BRIEF COMMUNICATIONS: CLINICALTranscatheter aortic valve implantation (TAVI) is an alterna-
tive to high-risk aortic valve replacement (AVR).1,2 There
are limited data on long-term outcomes.
CLINICAL SUMMARY
An 88-year-old man with symptomatic severe aortic ste-
nosis underwent percutaneous TAVI with a 26-mm SAPIEN
valve (Edwards Lifesciences LLC, Irvine, Calif). Comorbid
conditions included coronary artery bypass with patent ret-
rosternal grafts, transient ischemic attacks, bilateral carotid
endarterectomies, atrial fibrillation, repaired abdominal an-
eurysm, prostate cancer, and renal failure. Estimated 30-
day mortality for AVR was 35% by means of logistic Euro-
SCORE and 11.1% by means of the Society of Thoracic
Surgeons National Database Risk Calculator. The procedure
was performed without difficulty, but the final valve position
was suboptimal, being slightly low (ventricularly), with the
ventricular aspect of the stent abutting the anterior leaflet
of the mitral valve (MV). Moderate paravalvular aortic
regurgitation (AR) was treated with repeated balloon redila-
tion3 without altering the valve position. Six-month trans-
thoracic echocardiographic analysis showed trivial AR and
mitral regurgitation.
The patient presented 11 months after implantation with
fever and Streptococcus angiosus in blood cultures. Also
noted were a dental visit 6 weeks before and lack of compli-
ance with endocarditis prophylaxis. Transesophageal echo-
cardiographic analysis demonstrated mild-to-moderate
paravalvular AR, a 133 8–mm ruptured anterior mitral leaf-
let aneurysm contiguous with the aortic prosthesis, and se-
vere mitral regurgitation (Figure 1).
Redo sternotomy was performed during cardiopulmonary
bypass after cannulating the right axillary artery and right in-
ternal jugular vein. The bioprosthesis was well-seated below
the coronary arteries with incomplete endothelialization of
the uppermost struts and covered with nodular excrescences
(Figure 2). It withstood extraction while fully expanded but
was removable when grasped with forceps, which were
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peared to be related to the transcatheter stent and was re-
paired with bovine pericardium. AVR was performed with
a 25-mm bioprosthesis and the continuous suture technique.
The postoperative course was complicated by renal fail-
ure, pneumonia, delirium, and dysphagia. The patient re-
mained afebrile with a normal white blood cell count and
was discharged home 38 days postoperatively.
Light microscopy revealed collagen delamination and
acutely inflamed vegetational material on the transcatheter
valve cuspal surface. Significant cusp infiltration by neutro-
phils and gram-positive cocci confirmed endocarditis
(Figure 3).
DISCUSSION
Late complications of TAVI are largely unknown. Unlike
MV laceration during antegrade transfemoral implantation,4
we describe late MV injury/perforation, endocarditis, and
successful explantation of the transcatheter valve.
TAVI Positioning
Low TAVI positioning likely contributed to the outcome
reported. Until now, emphasis has been on landing the aortic
edge just cranial to the native aortic cusps to ensure fixation
and coronary clearance. A strategy focusing equally on the
ventricular and aortic extents of the stent and avoiding low
positioning might be warranted. Increased valve visibility
might also be beneficial. Although all transcatheter valves
could be susceptible to this complication, longer valves ex-
tending further into the ventricle would seem to be at higher
risk.
Paravalvular Leak and Endocarditis
Sequelae of AR include compromise to ventricular func-
tion, hemolysis, endocarditis, and MV leaflet aneurysm.5
Paravalvular leaks after TAVI are usually posteriorly lo-
cated, possibly because of rigidity/calcification of the fibrous
aortic annulus and anterior mitral leaflet (versus the more
conformable muscular aortic annulus anteriorly). In this
case the posterior jet possibly contributed to denuding the
mitral endothelium, aneurysm formation, or both. A moder-
ate or greater paravalvular leak warrants balloon redilation.
We believe this perforation was related to stent contact
causing erosion, transmitting infection, or both. No other re-
ports of MV perforation exist despite presumably low posi-
tioning in some, although this does not exclude significant
contact-related mitral injury in the noninfective setting.
Treatment of preexisting infections, preoperative dental con-
sultation, and strict endocarditis prophylaxis are advisable.ardiovascular Surgery c Volume 137, Number 6 1547
Brief CommunicationsFIGURE 1. Transesophageal echocardiographic evaluation of late severe mitral regurgitation. A, Two regurgitant jets were identified, one transvalvular
(arrow) and a second through a perforation in the anterior mitral leaflet (arrowhead). B, A ruptured aneurysm (arrow) of the anterior leaflet of the mitral
valve was present adjacent to the ventricular edge (arrowhead) of the implanted transcatheter aortic valve.
FIGURE 2. Infective endocarditis on the transcatheter aortic valve. A, Intraoperative view from the surgeon’s perspective; the right side of the image is
anterior, corresponding to a ‘‘right’’ transcatheter valve cusp in nearly standard orientation. B, Explanted transcatheter valve as seen from the aortic side
in the same orientation as above. The cusps appeared thickened and covered with nodular endocarditic excrescences; the ‘‘noncoronary’’ portion of the valve
stent (arrow) was deformed by the surgeon to facilitate explantation. The stent was crushed to explant it and reformed ex vivo, but the effects of surgical
removal were still apparent. C, Explanted transcatheter valve as seen from the ventricular side showing similar features.
FIGURE 3. Representative light micrograph of percutaneous aortic valve cuspal tissue showing acutely inflamed vegetational material on the cusp surface
(asterisk)with superficial permeation of cuspal tissue by inflammatory cells (arrow; A) and coccal bacteria within tissue planes of the cusp (double arrow; B).
A, Hematoxylin and eosin stain; B, Gram stain. Bar is representative of 100 mm in each image.
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Explantation of a SAPIEN valve is feasible, followed by
standard AVR without root replacement. In contrast, other
transcatheter valves more broadly fixed to the left ventricular
outflow tract, root, and/or tubular aorta might require more
complex high-risk operations after explantation.
Valve Stability and Pseudoendothelialization
Fears of calcium resorption leading to loss of valve fixa-
tion over the intermediate term are likely unfounded. In
this patient, despite minimal initial native aortic cusp calci-
fication, the valve was tenaciously fixed. Whether tissue
in-growth contributed is unclear. This valve, particularly
the uncovered upper stent cells, was not fully covered in
pseudoendothelium 11 months later. Although beneficial
near the coronary ostia (possibly caused by high flow),
retarded pseudoendothelialization might require antiplatelet
therapy postoperatively. Paravalvular leak might further dis-
rupt tissue coverage. Finally, cusp integrity was lost early,A new subspecialty in cardiac surge
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The future of cardiac surgery is an ongoing debate, prompted
by the dramatic development of percutaneous techniques
that actually reduce the indications for standard surgical
treatments.1,2 During the last 6 months, we have been faced
with 4 cases of complications from percutaneous procedures
related to entrapment of foreign bodies or lesions due to me-
chanical devices. Our main goal has been to retrieve these
devices and treat the underlying cardiac disease.
CLINICAL SUMMARIES
Patient 1
A 72-year-old man was scheduled for placement of elec-
tive left anterior descending artery stent in another hospital.
The patient had an atheromatous left common trunk. During
the procedure, the stent was entrapped at this level. The
patient was therefore transferred to our hospital. Under
cardiopulmonary bypass (CPB) and cardioplegic arrest, we
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The Journal of Thoracic and Cprobably accelerated by infection and high flow with (para-
valvular) AR. Further evaluation of long-term durability,
function, and tissue coverage is needed.
We thank Lise Matzke for assistance with obtaining the light
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removed the stent through the aorta (Figure 1). A complete
revascularization was performed by means of bilateral inter-
nal thoracic artery grafting.
Patient 2
A 74-year-old man who had a percutaneous coronary in-
tervention (PCI) on a diagonal branch was referred to our de-
partment because of an entrapped guide wire at the level of
the left common trunk, despite the endovascular attempt to
retrieve it. The patient was operated on, and under CPB
and cardioplegic arrest, the guide wire was removed by
a combined approach through the aorta and an arteriotomy
of the diagonal vessel. A left internal thoracic artery graft
was therefore implanted on the diagonal branch.
Patient 3
A 65-year-old man was admitted to our surgical depart-
ment with chest pain. He had undergone a transcatheter pat-
ent forame ovale closure with a 25-mm Amplatzer occluder
1 year prior. The transesophageal echocardiogram (TEE)
performed showed ‘‘penetration’’ of the left atrial disk of
the occluder into the left atrial wall and the posterior wall
of the aortic root. Amagnetic resonance image demonstrated
an extravasation of the dye from the left atrial cavity into the
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